Drug Approval | November 10, 2025
Glenmark secures China approval for Ryaltris
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
The integration of AHG’s specialized cold chain transportation and third-party logistics (3PL) solutions will significantly strengthen UPS Healthcare’s service offerings
Orphan drug designation (ODD) by the USFDA for Desidustat, provides eligibility for a potential seven-year marketing exclusivity subject to the USFDA approval
Enzomenib, an oral, small-molecule inhibitor designed to disrupt the menin-MLL protein interaction involved in leukemogenesis
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Kygevvi combines two pyrimidine nucleosides, doxecitine and doxribtimine, which act by integrating deoxycytidine and deoxythymidine into skeletal muscle mitochondrial DNA
Subscribe To Our Newsletter & Stay Updated
